GDR: Rapid pharmacogenetic testing adoption accelerates, with key NHS and international milestones ahead

Rapid pharmacogenetic testing solutions are driving revenue growth and adoption in the UK and internationally, with two CE-IVD certified products addressing critical clinical needs. Key milestones include NICE guidance and NHS England procurement in July 2027, international expansion, and a focus o…